sacituzumab
gilead
['sacituzumab', ' sg ', 'mbc', 'tropics02', 'sacitu, govi']
final overall survival results from the #tropics02 phase 3 trial presented by . sacituzumab govitecan significantly improved os over chemo irrespective of trop2 expression and her2-low status. reinforces the role of sg for chemo-refractory patients with hr+ mbc. #asco23 
Medical Oncologist, Research Fellow @DanaFarber | @Harvard | PhD @LaStatale | former @IEOufficiale. Interested in breast oncology, HER2, ADCs & good music.